David Anderson

FC Global Realty, Inc. engages in the acquisition, development, and management of commercial and residential real estate properties. It focuses on investments in high yield income producing assets and other opportunistic commercial properties via direct property ownership and asset management. The company was founded in 1980 and is headquartered in Willow Grove, PA.

Signal Pharmaceuticals Inc is pioneering the discovery and development of small molecule therapeutics which regulate the transcription factors involved in the progression of a number of inflammatory, viral and neurological diseases. The core technology for the company's research was discovered in the laboratories of three of its founders, and has been licensed from the University of California and the Salk Institute. (SB) It was located in San Diego, CA.

Realm Therapeutics Plc engages in the development of novel therapeutics. It focuses on the prescription treatments for immune mediated diseases in adults and children. The company was founded on April 21, 2006 and is headquartered in Malvern, PA.

Proprius Pharmaceuticals, Inc. develops, commercializes and markets pharmaceutical products. It provides personalized medicine services to rheumatologists. The company's product pipeline includes two early clinical-stage therapeutic candidates comprising a product to treat pain and a product to treat rheumatoid arthritis. Proprius Pharmaceuticals was founded by Michael J. Walsh in 2005 and is headquartered in San Diego, CA.

BioRez, Inc. engages in the design and development of resorbable polymer scaffold technology. The firm offers a device that is suited for tendon, ligament, and other soft tissue injuries. The company was founded by Cato T. Laurencin and Joseph W. Reilly in 2008 and is headquartered in New Haven, CT.

ACell, Inc. develops and manufactures bioscaffold, extracellular matrix technology for medical and veterinary products. It offers the next generation of regenerative medicine through the development and commercialization of unique extracellular matrix devices to repair and remodel damaged tissues and organs in a broad range of surgical procedures. The firm's products include ABRA, Cytal Burn Matrix, Cytal Wound Matrix, Gentrix Surgical Matrix and MicroMatrix. It is a regenerative medicine company that focuses on the development, manufacturing and sale of products primarily used in acute care settings as part of the treatment and management of moderate to severe wounds and reinforcement of soft tissue surgical defects. The firm’s products utilizes proprietary porcine urinary bladder matrix platform technology, which is designed to enhance the body's ability to restore natural tissue and minimize scarring in the management of traumatic, surgical and chronic wounds, burns, hernias and other conditions requiring the reinforcement of soft tissue. The company was founded by Stephen Xavier Graham in June 1999 and is headquartered in Columbia, MD.

Molecular Detection, Inc. develops and commercializes molecular diagnostic tests to detect infectious diseases. It offers Detect-Ready methicillin-resistant Staphylococcus aureus (MRSA) panel that allows for the detection of MRSA. The company was founded by Aryeh L. Gassel in 2007 and is headquartered in Wayne, PA.

Synergy Biomedical LLC is a privately held medical device company that was founded in 2011 by Mark Borden. The company is based in Wayne, PA. Synergy Biomedical is focused on bringing innovative and positively disruptive biomaterial-based products to the orthopedic and spinal markets. The company's Biosphere® technology represents a unique approach to advancing bone graft technology and improving bone healing and patient outcomes. The CEO is Kevin Booth.

Ignyta Operating, Inc. develops molecular diagnostics for cancer and immunology. It is a biotechnology company developing personalized medicines for high unmet need cancer indications, based on cancer genome mining and sequencing. The firm's products include TrailblazeDx for RA, TrailblazeTx for RA, TrailblazeDx for SLE, TrailblazePx for SLE and TrailblazeTx for SLE. The company was founded in August 2011 by Jonathan E. Lim and Gary S. Firestein and is headquartered in San Diego, CA.

LFC Financial Corp provides financial services. The private company is based in Radnor, PA.

MentorTech Management LLC (MentorTech Ventures) is an independent venture capital firm founded in 2005 by Michael B. Aronson and Boris M. Kalandar. The firm is headquartered in Philadelphia, Pennsylvania.

Gentis, Inc. engages in the development and testing technologies for the minimally invasive treatments. The company was founded by Charles Cohen and Paul Ducheyne in 2000 and is headquartered in Wayne, PA.

Replication Medical, Inc. develops implantable hydrogel devices. Its products include Enguard, Gelguard, GelFix and GelStix. The company was founded by Vladimir A. Stoy, Chuck G. Hadley and David W. Anderson in 2000 and is headquartered Monmouth Junction, NJ.

Orteq Ltd. develops advanced bioengineering solutions for orthopedic injuries. Its products include actifit, menisci and meniscal injuries and pipeline. The company was founded by David William Anderson and Peter van Wijk in 2005 and is headquartered in London, the United KIngdom.

Carmell Regen Med Corp. develops biomaterials manufactured from blood plasma. It offers biologically-active plastics from blood plasma for treating injuries to bone and connective tissue. The firm focuses on products for the sports medicine market with devices for the repair of tendon and cartilage injuries. It provides REPAIR Bone Putty, a putty form of the plasma-based plastics to fill bone defects; and surgical scaffold for soft tissue repair that heals injured tendons and ligaments. The company was founded by James Edward Burgess, Phil Campbell, and Lee E. Weiss in 2007 and is headquartered in Pittsburgh, PA.

Inion Ltd. manufactured medical equipment & devices. The company was headquartered at Godalming, Surrey.

City Hill Ventures LLC (City Hill Ventures) is a venture capital firm founded in 2010 by Jonathan Lim. The firm is headquartered in San Diego, California.

Fesariustherapeutics, Inc. is an American Brooklyn-based company that specializes in tissue repair biomaterial for reconstructive surgeons. The company's flagship product, Dermisphere™, is an intelligently patterned native-state hydrogel scaffold for dermal tissue regeneration. The scaffold is made of collagen microspheres incorporated in a self-assembling collagen hydrogel that provides an optimal environment for cells from surrounding healthy tissues to migrate into the hydrogel. The company was founded by Jason Spector, a renowned plastic surgeon, and has been led by CEO Thomas G. Roueche since 2021.

CellCoTec Ltd. develops surgery cell-based therapy and biomedical products. Its technology which combines cell interaction with the use of a mechanically functional polymer scaffold in a single surgical intervention. The company was founded by Jens Riesle and Jeanine Heendriks in 2004 and is headquartered in London, the United Kingdom.

Aperion Biologics, Inc. engages in the development and implementation of its business plans, performing research on its platform technology, conducting clinical trials on its products in both animals and humans, pursuing regulatory approvals to market its product in U.S. and international markets, and raising capital. The firm's core platform technology is an enzymatic stripping of the key carbohydrate antigens followed by a unique conversion process that both humanizes and sterilizes the tissues without affecting their biomechanical or biological properties. The company was founded by Kevin Robert Stone in October 1996 and is headquartered in San Antonio, TX.